These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11187369)

  • 1. Roundtable discussion. Achieving more aggressive low-density lipoprotein cholesterol lowering.
    Hunninghake DB; McKenney JM; Gotto AM; Mehta JL; Jones PH
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S1008-16. PubMed ID: 11187369
    [No Abstract]   [Full Text] [Related]  

  • 2. The economics of lipid management.
    Mullins CD
    Manag Care; 2001 Nov; 10(11 Suppl):17-8; discussion 19-24. PubMed ID: 11761626
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-cost intervention produces dramatic results in managing LDL cholesterol.
    Dis Manag Advis; 2001 Mar; 7(3):36-9, 33. PubMed ID: 11299511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying patients for aggressive cholesterol lowering: the risk curve concept.
    Robinson JG; Stone NJ
    Am J Cardiol; 2006 Nov; 98(10):1405-8. PubMed ID: 17134640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the value and affordability of cholesterol reduction in the managed care setting.
    Gonzalez ER; Kannewurf BS
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S226-33; quiz S234-5. PubMed ID: 10180344
    [No Abstract]   [Full Text] [Related]  

  • 6. Atherosclerosis target of lipid-lowering therapy: is lower LDL cholesterol better?
    Jones PH
    Am J Manag Care; 2003 Aug; Suppl():1, 4-5. PubMed ID: 13678393
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving cholesterol control in managed care populations.
    McKenney JM
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S997-1007. PubMed ID: 11187371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving cholesterol target in a managed care organization (ACTION) trial.
    Straka RJ; Taheri R; Cooper SL; Smith JC
    Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.
    Frolkis JP; Pearce GL; Sprecher DL
    Am J Cardiol; 2004 Nov; 94(10):1310-2. PubMed ID: 15541255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: missing the target with lipid-lowering therapy.
    Hunninghake DB; McKenney JM
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful management of lipid-lowering programs.
    Wright AT
    Manag Care; 2001 Nov; 10(11 Suppl):10-3; discussion 19-24. PubMed ID: 11761624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivering effective lipid management in the managed care setting: an interview with Leslee J. Shaw, PhD.
    Shaw LJ
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S323-6. PubMed ID: 12240704
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving target cholesterol levels in diabetic patients: potency of the statin or potency of the physician?
    Shani M; Dresner J; Vinker S
    Isr Med Assoc J; 2008 May; 10(5):354-7. PubMed ID: 18605358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol management and managed care.
    McBride PE
    J Fam Pract; 1997 May; 44(5):449-50. PubMed ID: 9152261
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals.
    Hirsch M; O'donnell J; Olsson A
    Int J Cardiol; 2005 Oct; 104(3):251-6. PubMed ID: 16186052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol.
    Goldberg KC; Melnyk SD; Simel DL
    Am J Manag Care; 2007 Sep; 13(9):530-4. PubMed ID: 17803367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.